Compare Amphastar Pharmaceuticals Inc (AMPH) vs Illinois Tool Works Inc. (ITW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Illinois Tool Works Inc. — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.74 (market cap $826.08M), while Illinois Tool Works Inc. trades at $270.17 (market cap $77.34B). The key difference: Illinois Tool Works Inc. is far larger — about 93.6× Amphastar Pharmaceuticals Inc's market cap, and Illinois Tool Works Inc. pays a 2.4% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | ITW | |
|---|---|---|
Market Cap | $826.08M | $77.34B |
Sector | Health | Industrials |
52-Week High | $30.81 | $299.60 |
52-Week Low | $16.87 | $241.07 |
Enterprise Value | $1.22B | $85.66B |
Dividend Yield | — | 2.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
ITW trades at $268.81, up 1.25% with a bullish technical signal and strong profitability metrics including 19.32% net margin and 96.88% ROE. Recent earnings beats and a $1.61 dividend payment reflect operational strength, though cash flow trends show slight volatility. The stock is near resistance at $268 with analyst consensus target of $284.50.
Outlook remains positive with consistent earnings outperformance and margin expansion from enterprise initiatives. Risks include construction sector weakness and currency exposure. Wall Street shows mixed sentiment with 21% buy ratings, suggesting cautious optimism amid near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →
